Abstract
SKF 38393, a selective D-1 dopamine receptor agonist, elevated plasma prolactin levels in eight patients with various neurological disorders. Growth hormone concentrations were unaffected by SKF 38393 administration. The results suggest that D-1 receptors may be involved in the regulation of prolactin secretion.
MeSH terms
-
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
-
Benzazepines / administration & dosage*
-
Dyskinesia, Drug-Induced / blood*
-
Dyskinesia, Drug-Induced / drug therapy
-
Female
-
Growth Hormone / blood
-
Humans
-
Huntington Disease / blood*
-
Huntington Disease / drug therapy
-
Male
-
Middle Aged
-
Parkinson Disease / blood*
-
Parkinson Disease / drug therapy
-
Prolactin / metabolism*
-
Receptors, Dopamine / drug effects
-
Receptors, Dopamine / physiology*
-
Receptors, Dopamine D1
Substances
-
Benzazepines
-
Receptors, Dopamine
-
Receptors, Dopamine D1
-
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
-
Prolactin
-
Growth Hormone